Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

This study has been withdrawn prior to enrollment.
(The study was limited to IRB Exempt chart review; not an applicable trial.)
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00323726
First received: May 5, 2006
Last updated: December 18, 2011
Last verified: December 2009
  Purpose

Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study


Condition
Ovarian Cancer

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

Resource links provided by NLM:


Further study details as provided by New Mexico Cancer Care Alliance:

Enrollment: 0
Study Start Date: December 2005
Study Completion Date: December 2006
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Detailed Description:

This is a chart review.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients with ovarian germ cell tumors

Criteria

Inclusion Criteria:

  • Patients with Ovarian Germ Cell Tumors in the last 27 years.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00323726

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico
  More Information

No publications provided

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00323726     History of Changes
Other Study ID Numbers: HRRC 02-579
Study First Received: May 5, 2006
Last Updated: December 18, 2011
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Ovarian Neoplasms
Neoplasms, Germ Cell and Embryonal
Germinoma
Endocrine Gland Neoplasms
Neoplasms by Site
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders
Neoplasms by Histologic Type

ClinicalTrials.gov processed this record on April 16, 2014